Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Zinc and Selenium Bioactivity in Modulating Immune Parameters in Tuberculosis

NCT07180329 is registered in ClinicalTrials.gov with University of Lahore as lead sponsor.

NCT NCT07180329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07180329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Zinc and Selenium Bioactivity in Modulating Immune Parameters in Tuberculosis
Lead sponsor
University of Lahore
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2023
Completion date
July 25, 2023
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunomodulatory drugs, tuberculosis